\n \n \n “. concat(self. i18n. t(‘search. voice. recognition_retry’), “\n
THOUSAND OAKS, Calif. , Feb. 3, 2022 /PRNewswire/ — Amgen (NASDAQ: AMGN) will host a virtual business review assembly at 8 a. m. m. ET Tuesday, February 8, 2022. Robert A. Bradway, president and chief executive officer, along with other members of Amgen’s control team, will provide a comprehensive review of the company’s strategy, operations, project portfolio, studio functions and expansion prospects. general public.
The webcast, along with other educational webcasts and presentations related to advances in Amgen’s business at medical and investor conferences, can be found on Amgen’s website, www. amgen. com, under the Investors tab.
Information related to presentation times, webcast availability, and webcast links is included in the Amgen Investor Relations Events Calendar. The webcast will be archived and playable for at least 90 days after the event.
About Amgen Amgen is committed to unlocking the perspective of biology for patients with serious illnesses by discovering, developing, producing and delivering cutting-edge human therapies. This technique begins with using equipment such as complex human genetics to get to the bottom of complexities. of disease and perceiving the foundations of human biology.
Amgen focuses on spaces where unmet medical need is paramount and draws on its expertise to seek answers that result in a physical state and dramatically people’s lives. A pioneer in biotechnology since 1980, Amgen has become one of the world’s leading independent biotechnology companies, reaching millions of patients. around the world, and a drug in development with disruptive potential is emerging.
Amgen is one of the 30 corporations that make up the Dow Jones Industrial Average and is also part of the Nasdaq-one hundred index. of the hundred most sustainable companies in the world through Barron’s.
For more information, visit www. amgen. com and follow us on www. twitter. com/amgen.
CONTACT: Amgen, Thousand Oaks Megan Fox, 805-447-1423 (media) Michael Strapazon, 805-313-5553 (media) Arvind Sood, 805-447-1060 (investors)
View content to download media: https://www. prnewswire. com/news-releases/amgen-to-host-virtual-business-review-meeting-301475127. html
SOURCEAmgen